<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36747962</PMID><DateRevised><Year>2023</Year><Month>02</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1614-3744</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1-2</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>CME (Berlin, Germany)</Title><ISOAbbreviation>CME (Berl)</ISOAbbreviation></Journal><ArticleTitle>[Not Available].</ArticleTitle><Pagination><StartPage>12</StartPage><EndPage>17</EndPage><MedlinePgn>12-17</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11298-022-3104-5</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pink</LastName><ForeName>Isabell</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>- Klinik f&#xfc;r Pneumologie -, Med. Hochschule Hannover, Carl-Neuberg-Str. 1, 30625 Hannover, Deutschland.</Affiliation><Identifier Source="GRID">grid.10423.34</Identifier><Identifier Source="ISNI">0000 0000 9529 9877</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Welte</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Medizinische Hochschule Hannover/MHH, Carl-Neuberg-Str. 1, 30625 Hannover, Deutschland.</Affiliation><Identifier Source="GRID">grid.10423.34</Identifier><Identifier Source="ISNI">0000 0000 9529 9877</Identifier></AffiliationInfo></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Risiko und H&#xe4;ufigkeit von Long-COVID.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>CME (Berl)</MedlineTA><NlmUniqueID>101765229</NlmUniqueID><ISSNLinking>1614-371X</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>7</Day><Hour>2</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36747962</ArticleId><ArticleId IdType="pmc">PMC9891882</ArticleId><ArticleId IdType="doi">10.1007/s11298-022-3104-5</ArticleId><ArticleId IdType="pii">3104</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV 2 infection. Nat Med. 2022;</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniou KM, Vasarmidi E, Russell A M et al. European respiratory society statement on long COVID-19 follow-up. Eur Respir J. 2022;</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9349784</ArticleId><ArticleId IdType="pubmed">35144991</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur. 2021;6:100122</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia C, Nilsson J, Zurbuchen Y et al. Systemic and mucosal antibody responses specific to SARS-CoV 2 during mild versus severe COVID-19. J Allergy Clin Immunol. 2021;147:545-57.e9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7677074</ArticleId><ArticleId IdType="pubmed">33221383</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia C, Zurbuchen Y, Taeschler P et al. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat Commun. 2022;13:446</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J et al. Long covid&#x2014;mechanisms, risk factors, and management. BMJ. 2021;</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhaeze T, Tremblay L, Lachance C et al. CD70 defines a subset of proinflammatory and CNS-pathogenic TH1/TH17 lymphocytes and is overexpressed in multiple sclerosis. Cell Mol Immunol. 2019;16:652-65</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6804668</ArticleId><ArticleId IdType="pubmed">30635649</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A'Court C et al. Management of post-acute covid-19 in primary care. BMJ. 2020;</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE et al. Short-term and long-term rates of postacute sequelae of SARS-coV 2 infection: a systematic review. JAMA Netw Open. 2021;4:e2128568</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Madhavan MV, Sehgal K et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26:1017-32</Citation><ArticleIdList><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Li X, Gu X et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med. 2022; https://doi.org/10.1016/S2213-2600(22)00126-6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue S, Hatakeyama J, Kondo Y et al. Post-intensive care syndrome: its pathophysiology, prevention, and future directions. Acute Med Surg. 2019;6:233-46</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6603316</ArticleId><ArticleId IdType="pubmed">31304024</ArticleId></ArticleIdList></Reference><Reference><Citation>Koczulla AR, Ankermann T, Behrends U et al. S1-Leitlinie Post-COVID/Long-COVID. Pneumologie. 2021;</Citation><ArticleIdList><ArticleId IdType="pubmed">34474488</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques KC, Silva CC, da Trindade SS et al. Reduction of cardiac autonomic modulation and increased sympathetic activity by heart rate variability in patients with long COVID. Front Cardiovasc Med. 2022;9:862001</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9098798</ArticleId><ArticleId IdType="pubmed">35571200</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O, Merino E, Leon-Ramirez J M et al. Post-acute COVID-19 syndrome. Incidence and risk factors: a mediterranean cohort study. J Infect. 2021;82:378-83</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601-15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>PHOSP-COVID Collaborative Group. Clinical characteristics with inflammation profiling of long COVID and association with 1 year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med. 2022</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. J Heart Lung Transplant. 2020;39:405-7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7118652</ArticleId><ArticleId IdType="pubmed">32362390</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Taylor S. NICE guideline on long covid. BMJ. 2020;</Citation><ArticleIdList><ArticleId IdType="pubmed">33361141</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626-31</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Welte T. Post-COVID syndrome&#x2014;more questions than answers. Dtsch Arztebl Int. 2022;</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9215270</ArticleId><ArticleId IdType="pubmed">35583038</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28:583-90</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>A clinical case definition of post COVID-19 condition by a Delphi consensus. (Erstellt: 6. Okt. 2021). Zugegriffen: 2. Nov. 2021</Citation></Reference><Reference><Citation>Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK - Office for National Statistics. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/6may2022. Zugegriffen: 28. Mai 2022</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>